AMPX vs GEO

AMPX exhibits weak deterministic health with a Piotroski F-Score of 1/9, indicating severe financial distress and poor operational efficiency, while the absence of an Altman Z-Score raises unquantified bankruptcy risk. Despite this, the stock is trading at a premium valuation (Forward P/E: 182.91, Price/Sales: 33.78) driven by extraordinary revenue growth (137.4% YoY) and strong earnings surprises (average +52.81% over last 4 quarters). Analyst consensus is strongly bullish with a 'strong_buy' rating and a $20.00 target, reflecting high growth expectations. Insider selling activity (8 transactions, $37.78M) introduces bearish sentiment, but the company's technical trend and recent price momentum suggest strong market confidence. The Graham Number and intrinsic value are unavailable, indicating no defensive margin of safety.

GEO presents a stark contrast between deep value and deteriorating financial health, highlighted by a weak Piotroski F-Score of 3/9. While the stock is significantly undervalued relative to its Graham Number ($21.47) and Intrinsic Value ($53.69), and boasts explosive YoY earnings growth of 117.7%, these fundamentals are offset by bearish insider sentiment and a 0/100 technical trend. The strong analyst consensus (Strong Buy) and low PEG ratio (0.74) suggest high upside potential, but the low F-Score indicates underlying operational or balance sheet weaknesses that necessitate caution.